source
- STAT+: Sanofi MS drug gets positive review in Europe following FDAA multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.STAT · 4mo ago↗ source
- Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejectionSanofi’s tolebrutinib is on track to get an approval in Europe for a type of multiple sclerosis even after receiving a complete response letter from the FDA in December. On Friday, the European Med…Endpoints · 4mo ago↗ source
- Pfizer’s strategy chief Andrew Baum steps down; Helus Pharma swaps out CEO after two months→ Ex-Citi analyst Andrew Baum has left his role as chief strategy and innovation officer at Pfizer, but he will be a senior strategic advisor to CEO Albert Bourla. BMO Capital Markets broke the new…